AquaBounty Technologies (AQB) Stock Price, News & Analysis

Company Overview

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.

Key Stats

• Today's Range: $1.16 to $1.32
• 50-Day Range: $0.71 to $1.28
• 52-Week Range: $0.47 to $1.62
• Volume: 359,651 shs
• Average Volume: 1.27 million shs
• Market Capitalization: $4.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AquaBounty Technologies Stock Analysis - MarketRank™

AquaBounty Technologies scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for AquaBounty Technologies.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of AquaBounty Technologies is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of AquaBounty Technologies is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

AquaBounty Technologies has a P/B Ratio of 0.30. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.29% of the float of AquaBounty Technologies has been sold short.

Short Interest Ratio / Days to Cover

AquaBounty Technologies has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in AquaBounty Technologies has recently decreased by 33.64%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

AquaBounty Technologies does not currently pay a dividend.

Dividend Growth

AquaBounty Technologies does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.29% of the float of AquaBounty Technologies has been sold short.

Short Interest Ratio / Days to Cover

AquaBounty Technologies has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in AquaBounty Technologies has recently decreased by 33.64%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: N/A

News Sentiment

AquaBounty Technologies has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for AquaBounty Technologies this week, compared to 0 articles on an average week.

Search Interest

Only 1 people have searched for AQB on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added AquaBounty Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, AquaBounty Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.20% of the stock of AquaBounty Technologies is held by insiders.

Percentage Held by Institutions

Only 8.92% of the stock of AquaBounty Technologies is held by institutions.

AQB Stock Analysis - Frequently Asked Questions

How have AQB shares performed this year?

AquaBounty Technologies' stock was trading at $0.6264 at the start of the year. Since then, AQB shares have increased by 98.8% and is now trading at $1.2450.

How were AquaBounty Technologies' earnings last quarter?

AquaBounty Technologies, Inc. (NASDAQ:AQB) issued its quarterly earnings data on Tuesday, August, 5th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.53) by $0.10.

When did AquaBounty Technologies' stock split?

AquaBounty Technologies shares reverse split before market open on Monday, October 16th 2023.The 1-20 reverse split was announced on Monday, October 16th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 16th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of AquaBounty Technologies?

Shares of AQB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of AquaBounty Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that AquaBounty Technologies investors own include Tesla (TSLA), NIO (NIO), Plug Power (PLUG), NVIDIA (NVDA), Riot Platforms (RIOT) and

Company Calendar

• Last Earnings: 8/05/2025
• Today: 9/05/2025
• Next Earnings (Estimated): 11/03/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Recreation
• Current Symbol: NASDAQ:AQB
• CIK: 1603978
• Web: www.aquabounty.com
• Phone: (978) 648-6000
• Fax: N/A
• Employees: 100
• Year Founded: 1991

Profitability

• EPS (Trailing Twelve Months): ($19.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$149.19 million
• Net Margins: N/A
• Pretax Margin: -44,301,480.00%
• Return on Equity: -224.83%
• Return on Assets: -158.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.30
• Quick Ratio: 0.30

Sales & Book Value

• Annual Sales: $2.47 million
• Price / Sales: 1.88
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.10 per share
• Price / Book: 0.29

Miscellaneous

• Outstanding Shares: 3,880,000
• Free Float: 3,793,000
• Market Cap: $4.64 million
• Optionable: No Data
• Beta: 1.28